DK2137539T3 - Amolorid følsomme calciumkanaler forbundet med paniklidelser - Google Patents
Amolorid følsomme calciumkanaler forbundet med paniklidelserInfo
- Publication number
- DK2137539T3 DK2137539T3 DK08715633.7T DK08715633T DK2137539T3 DK 2137539 T3 DK2137539 T3 DK 2137539T3 DK 08715633 T DK08715633 T DK 08715633T DK 2137539 T3 DK2137539 T3 DK 2137539T3
- Authority
- DK
- Denmark
- Prior art keywords
- panic disorder
- polymorphisms
- amoloride
- calcium channels
- channels associated
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/9406—Neurotransmitters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/30—Psychoses; Psychiatry
- G01N2800/301—Anxiety or phobic disorders
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Food Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
- Credit Cards Or The Like (AREA)
- Liquid Crystal Substances (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200700519 | 2007-04-03 | ||
PCT/DK2008/050080 WO2008119360A1 (en) | 2007-04-03 | 2008-04-03 | Amiloride sensitive sodium channels associated with panic disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2137539T3 true DK2137539T3 (da) | 2011-01-24 |
Family
ID=38312417
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK08715633.7T DK2137539T3 (da) | 2007-04-03 | 2008-04-03 | Amolorid følsomme calciumkanaler forbundet med paniklidelser |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP2137539B1 (da) |
AT (1) | ATE483985T1 (da) |
DE (1) | DE602008002913D1 (da) |
DK (1) | DK2137539T3 (da) |
WO (1) | WO2008119360A1 (da) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9371383B2 (en) | 2012-01-31 | 2016-06-21 | Regeneron Pharmaceuticals, Inc. | Anti-ASIC1 antibodies and uses thereof |
SG11201403222UA (en) | 2012-01-31 | 2014-07-30 | Regeneron Pharma | Anti-asic1 antibodies and uses thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2304494A1 (en) * | 2000-04-20 | 2001-10-20 | Philippe Seguela | A novel heteromultimeric ion channel receptor and uses thereof |
US20030186860A1 (en) * | 2002-03-29 | 2003-10-02 | Welsh Michael J. | Novel compositions and methods for modulating the acid-sensing ion channel (ASIC) |
-
2008
- 2008-04-03 DK DK08715633.7T patent/DK2137539T3/da active
- 2008-04-03 AT AT08715633T patent/ATE483985T1/de not_active IP Right Cessation
- 2008-04-03 EP EP08715633A patent/EP2137539B1/en not_active Not-in-force
- 2008-04-03 DE DE602008002913T patent/DE602008002913D1/de active Active
- 2008-04-03 WO PCT/DK2008/050080 patent/WO2008119360A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
EP2137539B1 (en) | 2010-10-06 |
EP2137539A1 (en) | 2009-12-30 |
WO2008119360A1 (en) | 2008-10-09 |
ATE483985T1 (de) | 2010-10-15 |
DE602008002913D1 (de) | 2010-11-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL301145I2 (nl) | Tirbanibulin | |
PH12018500045A1 (en) | Compositions and methods for treating and diagnosing asthma | |
TW200636075A (en) | Detection of nucleic acid variation by cleavage-amplification method | |
CY1117546T1 (el) | Eνωση διαμινο ετεροκυκλικου καρβοξαμιδιου | |
BRPI0513982A (pt) | inibidores de sinalização de receptor de vegf e receptor de hgf | |
EA200702048A1 (ru) | Фармакокинетически улучшенные соединения | |
MX2007014616A (es) | Inhibidores de señalizacion del receptor del factor a de crecimiento endotelial vascular y del receptor del factor de crecimiento de hepatocitos. | |
TW200720268A (en) | 1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent PARP inhibitors | |
BRPI0508254A (pt) | métodos e composições para o tratamento ou prevenção de distúrbios psiquiátricos com inibidores de cox-2 sozinhos e em combinação com agentes antidepressivos | |
EA200702203A1 (ru) | Способы и нуклеиновые кислоты для анализов клеточных пролиферативных нарушений | |
EA201270184A1 (ru) | Лечение расстройств печени ингибиторами pi3k | |
ATE461923T1 (de) | Substituierte 1h-benzimidazol-4-carbonsäureamide sind wirksame parp-inhibitoren | |
DK1664026T3 (da) | Inhibitorer af mitotisk kinesin | |
ATE446094T1 (de) | Mitotische kinesin-hemmer | |
EA200801046A1 (ru) | Неинвазивный способ выявления переходно-клеточной карциномы мочевого пузыря in vitro | |
BRPI0414792A (pt) | derivados de ácido 4-(1h-indol-3-il-metilidenoaminóxi-propóxi)-benzóico e compostos relacionados como inibidores de pai-1 para o tratamento de enfraquecimento do sistema fibrinolìtico e de trombose | |
WO2010036960A3 (en) | Methods for treating, diagnosing, and monitoring lupus | |
ATE538084T1 (de) | Bicyclische 1,4-retigabin-analoga als kaliumkanalhemmer | |
WO2008106594A3 (en) | Inhibitors of nucleophosmin (npm) and methods for inducing apoptosis | |
WO2009073575A3 (en) | Methods for treating induced cellular proliferative disorders | |
ATE540036T1 (de) | Heterocyclische derivate als ionenkanalmodulatoren | |
DE602008006254D1 (de) | Doppel-oligonukleotid-nukleinsäurenachweisverfahren | |
TW200716132A (en) | Novel chemical compounds | |
DK2137539T3 (da) | Amolorid følsomme calciumkanaler forbundet med paniklidelser | |
PT1529116E (pt) | Métodos para o tratamento da demência com base no genótipo da apo e |